B

Biogenosis

Europe, Liege, Belgium, Liège

Description

Biogenosis is a biotechnology company.

Investor Profile

Biogenosis has made 1 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (100%)

Country Focus

  • Belgium (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biogenosis frequently co-invest with?

Pfizer
North America, New York, United States, New York
Co-Investments: 1
Meusinvest (Noshaq)
Europe, Liege, Belgium, Liège
Co-Investments: 1
KU Leuven
Europe, Vlaams-Brabant, Belgium, Leuven
Co-Investments: 1
Epimède
Europe, Liege, Belgium, Liège
Co-Investments: 1
S.R.I.W.
Europe, Liege, Belgium, Liège
Co-Investments: 1
SFPI-FPIM
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1

What are some of recent deals done by Biogenosis?

Imcyse

Liège, Liege, Belgium

Developing disease specific immune therapies to treat severe, chronic auto-immune, inflammatory, allergic, infectious diseases and tumors.

BiotechnologyPharmaceuticalTherapeutics
Series BFeb 17, 2021
Amount Raised: $25,659,559